Skip to main content

Faculty Profile

Dhara SuratiDhara D. Surati

Clinical Associate Professor
Pharmacy Practice and Translational Research

University of Houston College of Pharmacy
Health 2, Room 4014
4349 Martin Luther King Boulevard
Houston, TX 77204-5039

Contact: - Office: 832-842-8346 - Fax: 832-842-8383

Research/Academic Interests:

  • Skills labs-based teaching
  • Active learning
  • Infectious diseases
  • Scholarship of teaching and learning
  • Doctor of Pharmacy, Summa Cum Laude, University of Houston College of Pharmacy, Houston, Texas
  • Clinical Research Curriculum, University of Texas Medical School, Houston, Texas, 2009 - present
  • 15th Annual Fellows Course in Hospital Epidemiology and Infection Control, July 6–8, 2011, Johns Hopkins University, Baltimore, Maryland
  • Infectious Diseases Fellow, University of Houston-College of Pharmacy, Houston, Texas, Mentors: Kevin W. Garey, Pharm.D., M.S., and Herbert L. DuPont, M.D.
  • PGY-1 Pharmacy Practice Resident, Memorial Hermann-Texas Medical Center, Houston, Texas, Program Director: Bradley Domonoske, Pharm.D., BCPS

  • Dotson KM, Aitken SL, Sofjan AK, Shah DN, Aparasu RR, Garey KW. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect. 2018 May 9; 9(1-5). doi: 10.1017/S0950268818001036. [Epub ahead of print]
  • Sofjan AK, Mitchell A, Shah DN, Nguyen T, Sim M, Trojcak A, Beyda ND, Garey KW. Rezafungin (CD101), a next generation echinocandin. A systematic literature review and assessment of possible place in therapy. J Glob Antimicrob Resist. 2018 Feb 24. pii: S2213-7165(18)30041-9. doi: 10.1016/j.jgar.2018.02.013. [Epub ahead of print]
  • Das J, Fernandez J, Shah D, Williams L, Zagaar M. Case-based studies in teaching medicinal chemistry in PharmD curriculum: Perspectives of students, faculty, and pharmacists from academia. Currents in Pharmacy Teaching and Learning. 10 (1). 85-89.
  • Shah DN, Chan FS, Kachru N, Garcia KP, Balcer HE, Dyer AP, Emanuel JE, Jordan MD, Lusardi KT, Naymick G, Polisetty RS, Sieman L, Tyler AM, Johnson ML, Garey KW. A multi-center study of fidaxomicin use for Clostridium difficile infection. Springerplus. 2016 Aug 2; 5(1): 1224. ecollection 2016.
  • Shah DN, Aitken SL, Barragan LF, Bozorgui S, Goddu S, Navarro ME, Xie Y, DuPont HL, Garey KW. Economic burden of primary compared with recurrent Clostridium difficile
  • Garey KW, Aitken SL, Gschwind L, Goddu S, Xie Y, Duff C, Barbut F, Shah DN, DuPont HL. Development and validation of a Clostridium difficile health-related quality-of-life questionnaire. J Clin Gastroenterol. 2016; 50(8): 631-7.
  • Kilic A, Alam MJ, Tisdel NL, Shah DN, Yapar M, Lasco TM, Garey KW. Multiplex real-time PCR method for simultaneous identification and toxigenic type characterization of Clostridium difficile from stool samples. Ann Lab Med. 2015 May; 35(3):306-13.
  • Na X, Martin AJ, Sethi S, Kyne L, Garey KW, Flores SW, Hu M, Shah DN, Shields K, Leffler DA, Kelly CP. A multi-center prospective and validation of a clinical prediction tool for severe Clostridium difficile infection. PLoS One. 2015 April; 10(4): eCollection 2015.
  • Aitken SL, Joseph TB, Shah DN, Lasco TM, Palmer HR, DuPont HL, Xie Y, Garey KW. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. PLoS One. 2014 Jul 24; 9(7):e102848.
  • Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: Role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Mar 31. [Epub ahead of print]
  • Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW. Assessment of treatment patterns and patient outcomes before vs. after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect. 2013; 85(1): 28-32.
  • Shah DN, Bhatt NS, Welch JK, Koo HL, Garey KW. Defining acute renal dysfunction as a criterion for Clostridium difficile infection severity in patients with community-onset vs. hospital-onset infection. J Hosp Infect. 2013; 83(4)294-9.
  • Beyda ND, Chuang SH, Alam MJ, Shah DN, Ng TM, McCaskey L, Garey KW. Treatment of Candida famata blood stream infections: case series and review of the literature. J Antimicrob Chemother. 2013; 68(2):438-43.
  • Shah DN, Yau R, Lasco TM, Weston J, Salazar M, Palmer HR, Garey KW. Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother. 2012; 56(6):3239-43.
  • Le F, Arora V, Shah DN, Salazar M, Palmer HR, Garey KW. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: Implications for antibiotic stewardship programs. Pharmacother. 2012; 32(2):129-34.

Awards & Honors

  • Excellence in Teaching University of Houston College of Pharmacy, 2021
  • Faculty Preceptor of the Year Award University of Houston College of Pharmacy, 2016